Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 11
Results: 31
Correction.
- Published in:
- 2022
- Publication type:
- Journal Article
Recent developments in cGMP research: From mechanisms to medicines and back.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2321, doi. 10.1111/bph.15824
- By:
- Publication type:
- Article
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2538, doi. 10.1111/bph.15822
- By:
- Publication type:
- Article
Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2577, doi. 10.1111/bph.15802
- By:
- Publication type:
- Article
Linking drug and food addiction via compulsive appetite.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2589, doi. 10.1111/bph.15797
- By:
- Publication type:
- Article
Assessing the fidelity of translation of non‐clinical assays: a Pharma perspective.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2564, doi. 10.1111/bph.15796
- Publication type:
- Article
Intra‐articular injection of triamcinolone acetonide sustains macrophage levels and aggravates osteophytosis during degenerative joint disease in mice.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2771, doi. 10.1111/bph.15780
- By:
- Publication type:
- Article
Bruton's TK regulates myeloid cell recruitment during acute inflammation.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2754, doi. 10.1111/bph.15778
- By:
- Publication type:
- Article
Microsomal prostaglandin E synthase‐1 is involved in the metabolic and cardiovascular alterations associated with obesity.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2733, doi. 10.1111/bph.15776
- By:
- Publication type:
- Article
A carvedilol analogue, VK‐II‐86, prevents hypokalaemia‐induced ventricular arrhythmia through novel multi‐channel effects.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2713, doi. 10.1111/bph.15775
- By:
- Publication type:
- Article
Transglutaminase 2: Development of therapeutic antibodies reveals four inhibitory epitopes and confirms extracellular function in fibrotic remodelling.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2697, doi. 10.1111/bph.15774
- By:
- Publication type:
- Article
Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high‐fat diet.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2678, doi. 10.1111/bph.15767
- By:
- Publication type:
- Article
The antibiotic drug trimethoprim suppresses tumour growth and metastasis via targeting Snail.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2659, doi. 10.1111/bph.15763
- By:
- Publication type:
- Article
Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine‐motivated behaviour.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2647, doi. 10.1111/bph.15762
- By:
- Publication type:
- Article
Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2631, doi. 10.1111/bph.15757
- By:
- Publication type:
- Article
A new class of 5‐HT<sub>2A</sub>/5‐HT<sub>2C</sub> receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2610, doi. 10.1111/bph.15756
- By:
- Publication type:
- Article
Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2558, doi. 10.1111/bph.15718
- By:
- Publication type:
- Article
Multidrug resistance proteins preferentially regulate natriuretic peptide‐driven cGMP signalling in the heart and vasculature.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2443, doi. 10.1111/bph.15593
- By:
- Publication type:
- Article
Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2476, doi. 10.1111/bph.15586
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2319, doi. 10.1111/bph.15554
- Publication type:
- Article
cGMP and mitochondrial K<sup>+</sup> channels—Compartmentalized but closely connected in cardioprotection.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2344, doi. 10.1111/bph.15536
- By:
- Publication type:
- Article
Constitutive protein kinase G activation exacerbates stress‐induced cardiomyopathy.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2413, doi. 10.1111/bph.15530
- By:
- Publication type:
- Article
Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2505, doi. 10.1111/bph.15527
- By:
- Publication type:
- Article
Angiotensin II augments renal vascular smooth muscle soluble GC expression via an AT<sub>1</sub> receptor–forkhead box subclass O transcription factor signalling axis.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2490, doi. 10.1111/bph.15522
- By:
- Publication type:
- Article
cGMP signalling in dorsal root ganglia and the spinal cord: Various functions in development and adulthood.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2361, doi. 10.1111/bph.15514
- By:
- Publication type:
- Article
Visualising and understanding cGMP signals in the cardiovascular system.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2394, doi. 10.1111/bph.15500
- By:
- Publication type:
- Article
The role of cGMP signalling in auditory processing in health and disease.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2378, doi. 10.1111/bph.15455
- By:
- Publication type:
- Article
Optogenetic tools for manipulation of cyclic nucleotides functionally coupled to cyclic nucleotide‐gated channels.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2519, doi. 10.1111/bph.15445
- By:
- Publication type:
- Article
Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2460, doi. 10.1111/bph.15425
- By:
- Publication type:
- Article
NO‐sensitive guanylyl cyclase in the lung.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2328, doi. 10.1111/bph.15345
- By:
- Publication type:
- Article
Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 11, p. 2430, doi. 10.1111/bph.15333
- By:
- Publication type:
- Article